METASTATIC COLORECTAL CANCER (MCRC)
Clinical trials for METASTATIC COLORECTAL CANCER (MCRC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CANCER (MCRC) trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER (MCRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug fruquintinib tested in Real-World colorectal cancer study
Disease control Recruiting nowThis study is observing 150 adults with metastatic colorectal cancer who have already tried standard treatments. They will take Fruquintinib as prescribed by their doctor. Researchers will track how well the drug controls the cancer, survival, side effects, and quality of life in…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated May 17, 2026 01:20 UTC
-
New combo aims to shrink Hard-to-Treat colon tumors
Disease control Recruiting nowThis study tests whether adding the experimental drug leronlimab to standard chemotherapy can shrink tumors in people with a common type of advanced colorectal cancer that has stopped responding to prior treatments. About 60 adults with microsatellite stable (MSS) metastatic colo…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated May 17, 2026 01:17 UTC
-
New hope for liver cancers: targeted chemo plus immune booster shows promise
Disease control Recruiting nowThis study tests whether adding an immune-boosting drug (PDS01ADC) to standard liver-directed chemotherapy can help people with certain cancers that have spread to the liver. About 70 adults with colorectal cancer, bile duct cancer, or adrenal cancer that is mainly in the liver w…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could keeping cetuximab after First-Line failure extend life in advanced colorectal cancer?
Disease control Recruiting nowThis phase 3 study tests whether continuing the targeted drug cetuximab along with chemotherapy after the first treatment stops working can help control metastatic colorectal cancer better than switching to a different drug (bevacizumab). About 480 adults whose tumors have specif…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: PHASE3 • Sponsor: University of Campania Luigi Vanvitelli • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
AI-Powered biopsy test could personalize colorectal cancer treatment
Diagnosis Recruiting nowThis study is testing a new diagnostic test called µCAN for people with metastatic colorectal cancer. The test uses a small sample of the tumor and combines it with artificial intelligence to find which drug might work best for each patient. Researchers want to see if the test ca…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: NA • Sponsor: Oncosyne AS • Aim: Diagnosis
Last updated May 17, 2026 01:31 UTC